Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes

NCT05591235 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type2diabetes
Insulin Resistance

Interventions

DRUG: Metformin
DRUG: Dapagliflozin
DRUG: Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone)

Sponsor

Nanjing First Hospital, Nanjing Medical University